. . . . . . . "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:19:21+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .